Can Awiqli Help Novo Nordisk Build a New Growth Engine Beyond GLP-1s?
Novo Nordisk NVO recently launched Awiqli (insulin icodec-abae) in the United States, introducing the first once-weekly basal insulin for…
Novo Nordisk’s Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US
Awiqli® offers adults with type 2 diabetes an alternative to daily basal insulin injections, reducing frequency of these weekly…
Novo Nordisk launches Awiqli, world’s first weekly basal insulin, in India | Industry News
Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, where diabetes…
Novo Nordisk India launches Awiqli: Once a week insulin injection can finally make diabetes easier to live with
For my colleague, every evening at 7 pm, the day came to a halt. No matter how busy…
Once-weekly insulin Awiqli launched in India for adults with Type 1 and Type 2 diabetes
Danish drugmaker Novo Nordisk on Wednesday launched Awiqli or insulin icodec, the world’s first once-weekly basal insulin for…
Novo Nordisk launches once-weekly insulin Awiqli in India for type 1 and type 2 diabetes
Danish drugmaker Novo Nordisk on Thursday, July 9, launched its once-weekly basal insulin injection, Awiqli, in India, as…
Novo Nordisk receives FDA approval for basal insulin Awiqli
Novo Nordisk has secured the US Food and Drug Administration (FDA) approval for Awiqli (insulin icodec-abae) injection 700…
Novo Nordisk’s Awiqli Gets FDA Approval for Type II Diabetes
Novo Nordisk NVO announced that the FDA has approved Awiqli injection as the first and only once-weekly, long-acting basal…
Novo Nordisk’s Awiqli Gets FDA Approval for Type II Diabetes
Novo Nordisk NVO announced that the FDA has approved Awiqli injection as the first and only once-weekly, long-acting basal…
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Novo Nordisk A/S Awiqli® (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA Awiqli®…
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Novo Nordisk A/S Awiqli® (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA Awiqli®…